EILSF makes first close of new healthcare fund, scores third exit this year with Gland Pharma

By Madhav A Chanchani

  • 28 Nov 2013

Life sciences-focused private equity fund EILSF (Evolvence India Life Sciences Fund), which has just struck a deal with buyout giant KKR & Co to sell its stake in Gland Pharma Ltd, has hit first close of its follow-on fund and is now looking to complete the fundraising process by the ......

This is a Premium article. Please subscribe or log in to read the full story!

Here's a selection of our recent premium content.

Already a member? Click here to log in.